Noema Pharma AG
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome (NCT06315751) | Noema Pharma AG | 2024-09-10 |
| A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause (NCT06385795) | Noema Pharma AG | 2024-04-22 |
| A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus) (NCT05583955) | Noema Pharma AG | 2022-07-25 |
| Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC (NCT05059327) | Noema Pharma AG | 2022-03-03 |
| An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. (NCT05217628) | Noema Pharma AG | 2022-01-11 |
| A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia (NCT06019338) | Noema Pharma AG | 2021-11-20 |
Track Noema Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.